Sumaham, Glenn R.

HRN: 27-58-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/14/2025
08/21/2025
IV
4.5g
Q8
Pneumoni On An Immunocompromised Host
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: